DISEASE INDICATIONS: Primary Biliary Cholangitis (PBC)
MANUFACTURER: Intercept Pharma Ltd
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Ocaliva, known by its generic name Obeticholic Acid, is a medication used to treat certain liver disorders, primarily primary biliary cholangitis (PBC). It is also being investigated for its potential use in other liver-related conditions.
